HROW: 20% | Harrow shares are trading higher after the company announced the manufacture of the first of three commercial-scale process performance qualification batches of TRIESENCE 40 mg/mL. Also the company announced that the second and third required PPQ batches are now scheduled
TPST: 74% | Tempest Therapeutics shares are trading higher after the company announced the TPST-1120 arm improved all efficacy endpoints vs SoC control in a study.
ACN: 9% | Accenture shares are trading higher. The company reported Q3 financial results